Horizon Kinetics’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$291K Buy
44,514
+15,524
+54% +$174K 0.01% 393
2018
Q3
$499K Buy
28,990
+4,035
+16% +$60K 0.01% 266
2018
Q2
$348K Sell
24,955
-732
-3% -$12.4K 0.01% 407
2018
Q1
$394K Sell
25,687
-4,655
-15% -$66.6K 0.01% 371
2017
Q4
$350K Buy
30,342
+9,498
+46% +$141K 0.01% 419
2017
Q3
$396K Buy
20,844
+3,337
+19% +$68.7K 0.01% 373
2017
Q2
$422K Sell
17,507
-3,568
-17% -$78.2K 0.01% 319
2017
Q1
$418K Buy
21,075
+4,511
+27% +$101K 0.01% 357
2016
Q4
$399K Buy
16,564
+1,841
+13% +$51.2K 0.01% 412
2016
Q3
$409K Sell
14,723
-2,873
-16% -$76K 0.01% 393
2016
Q2
$429K Buy
+17,596
New +$499K 0.01% 386

Other funds holding PGEN

Horizon Kinetics's PGEN Position: Q4 2018 in Review

Horizon Kinetics increased its Precigen (PGEN) stake by 54% in Q4 2018, buying an estimated $174K and bringing the position to 44,514 shares worth $291K. The position accounts for 0.01% of the portfolio, ranked #393.

Horizon Kinetics first reported a position in PGEN in Q2 2016 and has held it in 11 quarters since. The position peaked at $499K in Q3 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q4 2018.

  • Horizon Kinetics held 44,514 shares of Precigen worth $291K as of Q4 2018.
  • Horizon Kinetics bought 15,524 Precigen shares in Q4 2018, an estimated $174K.
  • Precigen made up 0.01% of Horizon Kinetics's portfolio in Q4 2018, its #393 holding.
  • Horizon Kinetics first reported a position in Precigen in Q2 2016 and has held it in 11 quarters since.
  • Horizon Kinetics's Precigen position peaked at $499K in Q3 2018.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.